ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08728
-0,02%
Bitcoin
66.674,83
0,60%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Pro-Pharmaceuticals, (PRW)

  7. Pro-Pharmaceuticals, (PRW) News

PRW

Pro (PRW)

Pro-Pharmaceuticals,
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:PRW
DatumZeitQuelleÜberschriftSymbolFirma
05/01/200923h00Edgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
31/12/200813h00Business WirePro-Pharmaceuticals Provides Year-End UpdateAMEX:PRWPro-Pharmaceuticals,
20/11/200813h00Edgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
20/11/200813h00Business WirePro-Pharmaceuticals Files Registration Statement for Rights Offering to Its ShareholdersAMEX:PRWPro-Pharmaceuticals,
19/11/200823h23Edgar (US Regulatory)Securities Registration Statement (S-1)AMEX:PRWPro-Pharmaceuticals,
14/11/200813h00Business WirePro-Pharmaceuticals to Commence Rights Offering to ShareholdersAMEX:PRWPro-Pharmaceuticals,
13/11/200822h17Edgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
13/11/200822h15Business WirePro-Pharmaceuticals Receives Delisting Notice from NYSE Alternext USAMEX:PRWPro-Pharmaceuticals,
07/11/200813h31Edgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
07/11/200813h30Business WirePro-Pharmaceuticals Reports Third Quarter ResultsAMEX:PRWPro-Pharmaceuticals,
07/11/200813h17Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:PRWPro-Pharmaceuticals,
06/11/200813h00Business WirePro-Pharmaceuticals to Present Corporate Update at the Rodman & Renshaw Annual Global Investment ConferenceAMEX:PRWPro-Pharmaceuticals,
06/10/200813h00Business WirePro-Pharmaceuticals' Pre-NDA Meeting Scheduled with FDAAMEX:PRWPro-Pharmaceuticals,
23/09/200817h27Edgar (US Regulatory)Pro Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)AMEX:PRWPro-Pharmaceuticals,
18/09/200813h00Business WirePro-Pharmaceuticals' Management Outlines Strategic InitiativesAMEX:PRWPro-Pharmaceuticals,
28/08/200813h00Business WireFDA Grants IND for Pro-Pharmaceuticals' DAVANAT(R) to Treat Breast Cancer PatientAMEX:PRWPro-Pharmaceuticals,
08/08/200813h10Edgar (US Regulatory)Pro Pharmaceuticals Inc - Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
08/08/200813h05Business WirePro-Pharmaceuticals Reports Second Quarter ResultsAMEX:PRWPro-Pharmaceuticals,
08/08/200812h55Edgar (US Regulatory)Pro Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:PRWPro-Pharmaceuticals,
06/08/200813h00Business WirePro-Pharmaceuticals Granted Pre-IND Meeting for Anti-Hypoxia DrugAMEX:PRWPro-Pharmaceuticals,
04/08/200813h00Business WireAmex Accepts Pro-Pharmaceuticals Compliance PlanAMEX:PRWPro-Pharmaceuticals,
15/07/200813h00Business WirePro-Pharmaceuticals Has Requested a Pre-IND Meeting with the U.S. Food and Drug AdministrationAMEX:PRWPro-Pharmaceuticals,
11/07/200813h00Business WirePro-Pharmaceuticals' Senior Executives to Be Featured on PBS' "Wealth & Wisdom"AMEX:PRWPro-Pharmaceuticals,
10/07/200813h00Business WirePro-Pharmaceuticals Appoints Noted Pioneer in Liver Diseases, Scott L. Friedman, M.D., to Scientific Advisory BoardAMEX:PRWPro-Pharmaceuticals,
09/07/200813h00Business WirePro-Pharmaceuticals and Sanghyon Chemical Ink Historic Agency AgreementAMEX:PRWPro-Pharmaceuticals,
25/06/200813h00Business WirePro-Pharmaceuticals' Executives Contribute to Definitive Book on GalectinsAMEX:PRWPro-Pharmaceuticals,
20/06/200815h20Edgar (US Regulatory)Pro Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:PRWPro-Pharmaceuticals,
20/06/200812h00Edgar (US Regulatory)Pro Pharmaceuticals Inc - Notice of Effectiveness (EFFECT)AMEX:PRWPro-Pharmaceuticals,
10/06/200813h02Edgar (US Regulatory)Pro Pharmaceuticals Inc - Withdrawal of Registration Statement (RW)AMEX:PRWPro-Pharmaceuticals,
02/06/200822h32Edgar (US Regulatory)Pro Pharmaceuticals Inc - Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
 Showing the most relevant articles for your search:AMEX:PRW

Kürzlich von Ihnen besucht

ASX
ANZLOT
XE
CPYG
Coinshares Digital Secur...
COIN
BAMBOOUST
Bamboo Token
NASDAQ
KIRK
Kirklands
BIT
S28290
Societe Generale Effekten
NASDAQ
FTGHX
Franklin SmallMid Cap Gr...
USOTC
MAAL
Marketing Alliance (PK)
COIN
CRPHTBTC
Crypthealth
BIT
F15191
Vontobel Financial Produ...
NASDAQ
PGIJX
PGIM ESG Short Duration ...
COIN
CLNEUR
EU
H934T
H934T
ASX
PKR
BIT
F12526
Vontobel Financial Produ...
NASDAQ
ABACJXX
Goldman Sachs Bank Usa C...
LSE
MROB
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten